This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Watermann, D. O. Articles by Stickeler, E. Search for Related Content PubMed PubMed Citation Articles by Watermann, D. O. Articles by Stickeler, E.

Splicing Factor Tra2-ß1 Is Specifically Induced in Breast Cancer and Regulates Alternative Splicing of the CD44 Gene

Departments of ¹ Obstetrics and Gynecology, and ² Pathology, University of Freiburg, Freiburg, Germany and ³ Institute of Biochemistry, University of Erlangen-Nuremberg, Erlangen, Germany

Requests for reprints: Elmar Stickeler, Department of Obstetrics and Gynecology, University of Freiburg, Hugstetterstr. 55, 79106 Freiburg, Germany. Phone: 49-761-270-3148; Fax: 49-761-270-3148; E-mail: stickeler{at}frk.ukl.uni-freiburg.de.

The human CD44 gene undergoes extensive alternative splicing of multiple variable exons positioned in a cassette in the middle of the gene. Expression of alternative exons is often restricted to certain tissues and could be associated with tumor progression and metastasis of several human malignancies, including breast cancer. Exon v4 contains multiple copies of a C/A-rich exon enhancer sequence required for optimal inclusion of the exon and binding to the nucleic acid–binding proteins YB-1 and human Tra2-ß1. Here, we show that hTra2-ß1, a member of the extended family of serine/arginine-rich (SR) splicing factors, enhances the in vivo inclusion of CD44 exons v4 and v5. It increased inclusion of exons v4 and v5 and acted synergistically with YB-1. Activation required the C/A-rich enhancer within exon v4. Several other SR proteins had none or only a slight effect on CD44 exon inclusion. In contrast, SC35 inhibited exon usage and antagonized the effects of Tra2 or YB-1. In a matched pair analysis of human breast cancers and their corresponding nonpathologic tissue controls, we found a significant induction of Tra2-ß1 in invasive breast cancer, both on the RNA and protein levels. Together with our functional data, these results suggest an important role for Tra2-ß1 in breast cancer. Induction of this splicing factor might be responsible for splicing of CD44 isoforms associated with tumor progression and metastasis. (Cancer Res 2006; 66(9): 4774-80)

This article has been cited by other articles:

				K. Takeo, T. Kawai, K. Nishida, K. Masuda, S. Teshima-Kondo, T. Tanahashi, and K. Rokutan Oxidative stress-induced alternative splicing of transformer 2{beta} (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells Am J Physiol Cell Physiol, August 1, 2009; 297(2): C330 - C338. [Abstract] [Full Text] [PDF]

				R. J. Katzenberger, M. S. Marengo, and D. A. Wassarman Control of Alternative Splicing by Signal-dependent Degradation of Splicing-regulatory Proteins J. Biol. Chem., April 17, 2009; 284(16): 10737 - 10746. [Abstract] [Full Text] [PDF]

				M. Hirschfeld, A. zur Hausen, H. Bettendorf, M. Jager, and E. Stickeler Alternative Splicing of Cyr61 Is Regulated by Hypoxia and Significantly Changed in Breast Cancer Cancer Res., March 1, 2009; 69(5): 2082 - 2090. [Abstract] [Full Text] [PDF]

				J. P. Venables, R. Klinck, A. Bramard, L. Inkel, G. Dufresne-Martin, C. Koh, J. Gervais-Bird, E. Lapointe, U. Froehlich, M. Durand, et al. Identification of Alternative Splicing Markers for Breast Cancer Cancer Res., November 15, 2008; 68(22): 9525 - 9531. [Abstract] [Full Text] [PDF]

				M. A. Rey, S. P. Duffy, J. K. Brown, J. A. Kennedy, J. E. Dick, Y. Dror, and C. S. Tailor Enhanced alternative splicing of the FLVCR1 gene in Diamond Blackfan anemia disrupts FLVCR1 expression and function that are critical for erythropoiesis Haematologica, November 1, 2008; 93(11): 1617 - 1626. [Abstract] [Full Text] [PDF]

				A. M. Eiring, P. Neviani, R. Santhanam, J. J. Oaks, J. S. Chang, M. Notari, W. Willis, C. Gambacorti-Passerini, S. Volinia, G. Marcucci, et al. Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis Blood, January 15, 2008; 111(2): 816 - 828. [Abstract] [Full Text] [PDF]

				T. Novoyatleva, B. Heinrich, Y. Tang, N. Benderska, M. E.R. Butchbach, C. L. Lorson, M. A. Lorson, C. Ben-Dov, P. Fehlbaum, L. Bracco, et al. Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing Hum. Mol. Genet., January 1, 2008; 17(1): 52 - 70. [Abstract] [Full Text] [PDF]

				P. Dewing, M. I. Boulware, K. Sinchak, A. Christensen, P. G. Mermelstein, and P. Micevych Membrane Estrogen Receptor-{alpha} Interactions with Metabotropic Glutamate Receptor 1a Modulate Female Sexual Receptivity in Rats J. Neurosci., August 29, 2007; 27(35): 9294 - 9300. [Abstract] [Full Text] [PDF]

				M. A. Calderwood, K. Venkatesan, L. Xing, M. R. Chase, A. Vazquez, A. M. Holthaus, A. E. Ewence, N. Li, T. Hirozane-Kishikawa, D. E. Hill, et al. Epstein-Barr virus and virus human protein interaction maps PNAS, May 1, 2007; 104(18): 7606 - 7611. [Abstract] [Full Text] [PDF]

				J. Qi, S. Su, M. E. McGuffin, and W. Mattox Concentration dependent selection of targets by an SR splicing regulator results in tissue-specific RNA processing Nucleic Acids Res., December 4, 2006; 34(21): 6256 - 6263. [Abstract] [Full Text] [PDF]